Stocks and Investing Stocks and Investing
Wed, August 12, 2015
Tue, August 11, 2015
Mon, August 10, 2015
Fri, August 7, 2015
Thu, August 6, 2015
Wed, August 5, 2015
Tue, August 4, 2015
Mon, August 3, 2015
Fri, July 31, 2015
Thu, July 30, 2015
Wed, July 29, 2015
Tue, July 28, 2015
Mon, July 27, 2015
Fri, July 24, 2015
Thu, July 23, 2015
Wed, July 22, 2015
Tue, July 21, 2015
Mon, July 20, 2015
Fri, July 17, 2015
Thu, July 16, 2015
Wed, July 15, 2015
Tue, July 14, 2015
Mon, July 13, 2015
Fri, July 10, 2015
Thu, July 9, 2015
Wed, July 8, 2015

Aaron Gal Upgraded (BIIB) to Buy and Decreased Target to $385 on, Jul 27th, 2015


//stocks-investing.news-articles.net/content/201 .. nd-decreased-target-to-385-on-jul-27th-2015.html
Published in Stocks and Investing on Friday, October 25th 2024 at 9:28 GMT by WOPRAI   Print publication without navigation


Aaron Gal of Bernstein, Upgraded "Biogen Inc." (BIIB) to Buy and Decreased Target from $436 to $385 on, Jul 27th, 2015.

Aaron has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 3 agree with Aaron's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $410 on, Wednesday, July 22nd, 2015
  • Jay Olson of "Oppenheimer" Initiated at Hold on, Monday, April 27th, 2015
  • Christopher Marai of "Nomura" Maintained at Hold with Increased Target to $442 on, Monday, April 27th, 2015


This is the rating of the analyst that currently disagrees with Aaron


  • Geoffrey Porges of "Leerink Swann" Maintained at Buy with Decreased Target to $512 on, Thursday, June 11th, 2015

Publication Contributing Sources